District of Columbia § 47-2885.13 Deteriorating drugs; sample drugs; returned drugs.

District of Columbia Statutes

§ 47-2885.13 — Deteriorating drugs; sample drugs; returned drugs.

District of Columbia § 47-2885.13

JurisdictionDistrict of Columbia

Title 47Taxation, Licensing, Permits, Assessments, and Fees. [Enacted title]

Ch. 28General License Law.

Subch. IVOther Licenses.

Part CPharmacy.

This text of District of Columbia § 47-2885.13 (Deteriorating drugs; sample drugs; returned drugs.) is published on Counsel Stack Legal Research, covering District of Columbia primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook

D.C. Code § 47-2885.13 (2026).

Text

(a)Drugs which may deteriorate shall at all times be stored under conditions specified on the label of the original container and in accordance with applicable District of Columbia or federal laws or regulations, and shall not be sold or dispensed after the expiration date designated on the label of the original container, and in accordance with applicable District of Columbia or federal laws or regulations.

(b)Drugs designated “sample” shall not be sold.

(c)A drug which has been returned after leaving the pharmacy shall not be placed in stock for reuse or resale, except manufacturer packaged unit dose or unit of use drugs which have been unopened and unaltered.

Free access — add to your briefcase to read the full text and ask questions with AI

(a) Drugs which may deteriorate shall at all times be stored under conditions specified on the label of the original container and in accordance with applicable District of Columbia or federal laws or regulations, and shall not be sold or dispensed after the expiration date designated on the label of the original container, and in accordance with applicable District of Columbia or federal laws or regulations.

(b) Drugs designated “sample” shall not be sold.

(c) A drug which has been returned after leaving the pharmacy shall not be placed in stock for reuse or resale, except manufacturer packaged unit dose or unit of use drugs which have been unopened and unaltered.